title: Failure of sugammadex to reverse rocuronium-induced neuromuscular blockade: Simply an outlier or are we missing something?
authors.affiliation: From the Department of Anaesthesiology, AZSint Jan Brugge-Oostende, Brugge (JPM), Department of Anaesthesiology, University of Louvain, CHU UCL Mont-Godinne-Dinant, Yvoir (PD), Department of Anaesthesiology and Pain Medicine, Martini General Hospital Groningen, Groningen, The Netherlands (HDDB), and Department of Anaesthesiology, University of Ghent, Gent, Belgium (LD).
authors.forename: Jan P
authors.initials: JP
authors.lastname: Mulier
authors.forename: Philippe E
authors.initials: PE
authors.lastname: Dubois
authors.forename: Hans D
authors.initials: HD
authors.lastname: de Boer
authors.forename: Luc
authors.initials: L
authors.lastname: Debaerdemaeker
mesh_terms: D000732:Androstanols / Q000009:adverse effects*; D006801:Humans; D008297:Male; D019148:Neuromuscular Blockade / Q000009:adverse effects* / Q000379:methods*; D047408:gamma-Cyclodextrins / Q000008:administration & dosage*
chemical_list: D000732:Androstanols; D047408:gamma-Cyclodextrins